| Alternative splicing of human inducible nitric-oxide synthase mRNA: tissue-specific regulation and induction by cytokines NT Eissa, AJ Strauss, CM Haggerty, EK Choo, SC Chu, J Moss Journal of biological chemistry 271 (43), 27184-27187, 1996 | 143 | 1996 |
| Transcriptional autoregulation by BRCA1 A De Siervi, P De Luca, JS Byun, LJ Di, T Fufa, CM Haggerty, E Vazquez, ... Cancer research 70 (2), 532-542, 2010 | 98 | 2010 |
| Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization NT Eissa, JW Yuan, CM Haggerty, EK Choo, CD Palmer, J Moss Proceedings of the National Academy of Sciences 95 (13), 7625-7630, 1998 | 94 | 1998 |
| Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes JS Byun, MM Wong, W Cui, G Idelman, Q Li, A De Siervi, S Bilke, ... Proceedings of the National Academy of Sciences 106 (46), 19286-19291, 2009 | 64 | 2009 |
| Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment JL Smith, WJ Freebern, I Collins, A De Siervi, I Montano, CM Haggerty, ... Proceedings of the National Academy of Sciences 101 (32), 11554-11559, 2004 | 61 | 2004 |
| Identification of new Rel/NFêB regulatory networks by focused genome location analysis A De Siervi, P De Luca, C Moiola, G Gueron, R Tongbai, ... Cell Cycle 8 (13), 2093-2100, 2009 | 48 | 2009 |
| ELL facilitates RNA polymerase II pause site entry and release JS Byun, TD Fufa, C Wakano, A Fernandez, CM Haggerty, MH Sung, ... Nature communications 3 (1), 633, 2012 | 47 | 2012 |
| Selective leukemic-cell killing by a novel functional class of thalidomide analogs Y Ge, I Montano, G Rustici, WJ Freebern, CM Haggerty, W Cui, ... Blood 108 (13), 4126-4135, 2006 | 37 | 2006 |
| Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells WG Butscher, CM Haggerty, S Chaudhry, K Gardner Journal of Biological Chemistry 276 (29), 27647-27656, 2001 | 29 | 2001 |
| Targeting combinatorial transcriptional complex assembly at specific modules within the interleukin-2 promoter by the immunosuppressant SB203580 JL Smith, I Collins, GVR Chandramouli, WG Butscher, E Zaitseva, ... Journal of Biological Chemistry 278 (42), 41034-41046, 2003 | 23 | 2003 |
| Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations G Idelman, JG Taylor, R Tongbai, RA Chen, CM Haggerty, S Bilke, ... Human mutation 28 (8), 824-829, 2007 | 22 | 2007 |
| Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene S Chaudhry, WJ Freebern, JL Smith, WG Butscher, CM Haggerty, ... The Journal of Immunology 169 (12), 6767-6778, 2002 | 22 | 2002 |
| Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase NT Eissa, CM Haggerty, CD Palmer, W Patton, J Moss American journal of respiratory cell and molecular biology 24 (5), 616-620, 2001 | 21 | 2001 |
| Transcriptional networks inferred from molecular signatures of breast cancer R Tongbai, G Idelman, SH Nordgard, W Cui, JL Jacobs, CM Haggerty, ... The American journal of pathology 172 (2), 495-509, 2008 | 17 | 2008 |
| Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells* 210 WJ Freebern, JL Smith, SS Chaudhry, CM Haggerty, K Gardner Journal of Biological Chemistry 278 (4), 2249-2255, 2003 | 17 | 2003 |
| Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2, 4-difluoro-phenyl)-4, 5, 6, 7-tetrafluoro-1H … Y Ge, JS Byun, P De Luca, G Gueron, IM Yabe, SG Sadiq-Ali, WD Figg, ... Molecular pharmacology 74 (3), 872-883, 2008 | 16 | 2008 |
| Multimembrane dot-blotting: a cost-effective tool for proteome analysis MM Galperin, JL Traicoff, A Ramesh, WJ Freebern, CM Haggerty, ... Biotechniques 36 (6), 1046-1051, 2004 | 15 | 2004 |
| Pharmacologic profiling of transcriptional targets deciphers promoter logic WJ Freebern, CM Haggerty, I Montano, MC McNutt, I Collins, A Graham, ... The Pharmacogenomics Journal 5 (5), 305-323, 2005 | 13 | 2005 |
| Human promoter genomic composition demonstrates non-random groupings that reflect general cellular function MC McNutt, R Tongbai, W Cui, I Collins, WJ Freebern, I Montano, ... BMC bioinformatics 6, 1-23, 2005 | 6 | 2005 |
| Profiling the expression of mitogen-induced T-cell proteins by using multi-membrane dot-blotting JL Traicoff, MM Galperin, A Ramesh, WJ Freebern, CM Haggerty, ... Biochemical and biophysical research communications 323 (1), 355-360, 2004 | 6 | 2004 |
